{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:07:59Z","timestamp":1762160879565,"version":"3.38.0"},"reference-count":8,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[1998,11,1]],"date-time":"1998-11-01T00:00:00Z","timestamp":909878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1998,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The effects of intragastric and intraduodenal copper-aspirin complex on rabbit platelet aggregation were observed by Born\u2019s method. Myers\u2019s method was used to evaluate the antithrombotic effect of copper-aspirin complex in mice.<\/jats:p><jats:p>In-vitro copper-aspirin complex selectively inhibited arachidonic acid-induced platelet aggregation with an IC50 value (concentration resulting in 50% inhibition) of 13.2 \u03bcM (95% confidence limits 9.1\u201316.8 \u03bcM). Copper-aspirin complex (10 mg kg\u22121 given intragastrically or intraduodenally) was more potent than aspirin in inhibiting arachidonic acid-induced platelet aggregation. Copper-aspirin complex (10 mg kg\u22121) had a stronger inhibitory effect and a longer duration of action when given intragastrically than when given intraduodenally. It was shown by radioimmunoassay that copper-aspirin complex significantly reduced the level of thromboxane B2 in plasma while markedly increasing that of 6-ketoprostaglandin F1\u03b1 (6keto-PGF1\u03b1). Copper-aspirin complex (10 mg kg\u22121 given intragastrically for 7 days) significantly reduced mouse mortality caused by intravenous injection of arachidonic acid.<\/jats:p><jats:p>The results suggest that both in-vitro and in-vivo copper-aspirin complex is more potent in selectively inhibiting arachidonic acid-induced platelet aggregation than aspirin. When given intragastrically the complex has a more potent antiplatelet effect and a longer duration of action than when given intraduodenally. The antithrombotic effect of the complex was more potent than that of aspirin.<\/jats:p>","DOI":"10.1111\/j.2042-7158.1998.tb03345.x","type":"journal-article","created":{"date-parts":[[2011,4,13]],"date-time":"2011-04-13T15:02:43Z","timestamp":1302706963000},"page":"1275-1279","source":"Crossref","is-referenced-by-count":4,"title":["Effects of Copper-aspirin Complex on Platelet Aggregation and Thrombosis in Rabbits and Mice"],"prefix":"10.1093","volume":"50","author":[{"given":"Z Q","family":"Shen","sequence":"first","affiliation":[{"name":"Yunnan Pharmacological Laboratories of Natural Products, Kunming Medical College , Kunming 650031"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Liang","sequence":"additional","affiliation":[{"name":"Yunnan Pharmacological Laboratories of Natural Products, Kunming Medical College , Kunming 650031"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z H","family":"Chen","sequence":"additional","affiliation":[{"name":"Yunnan Pharmacological Laboratories of Natural Products, Kunming Medical College , Kunming 650031"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W P","family":"Liu","sequence":"additional","affiliation":[{"name":"Kunming Institute of Precious Metals , Kunming 650221"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Duan","sequence":"additional","affiliation":[{"name":"Department of Imageology, 1st Affiliated Hospital of Kunming Medical College , Kunming 650032,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1998,11,1]]},"reference":[{"key":"2024103110013940900_cit1","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/194927b0","article-title":"Aggregation of blood platelets by adenosine diphosphate and its reversal","volume":"194","author":"Born","year":"1962","journal-title":"Nature"},{"key":"2024103110013940900_cit2","first-page":"1","article-title":"Studies on the analgesic activity, toxicity and side effects of copper aspirin","volume":"17","author":"Li","year":"1996","journal-title":"Acad. J. Kunming Med. Coll."},{"key":"2024103110013940900_cit3","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0049-3848(94)90280-1","article-title":"Human fibroblast cells produce a factor that stimulates prostacyclin synthesis by vascular endothelial cells","volume":"76","author":"Masakado","year":"1994","journal-title":"Thromb. Res."},{"key":"2024103110013940900_cit4","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3181\/00379727-183-42390","article-title":"Comparison of verapamil and nifedipine in thrombosis models","volume":"183","author":"Myers","year":"1986","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"2024103110013940900_cit5","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0022-3565(25)33481-6","article-title":"Thromboxane agonism and antagonism in a mouse sudden-death model","volume":"224","author":"Myers","year":"1983","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2024103110013940900_cit6","first-page":"133","article-title":"Overview of physiological and pathophysiological effects of thromboxane A2","volume":"46","author":"Ogletree","year":"1987","journal-title":"Fed. Proc."},{"key":"2024103110013940900_cit7","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0006-2952(90)90065-S","article-title":"Non-steroidal anti-inflammatory drug-copper complex modulation of polymorphonuclear leukocyte migration","volume":"39","author":"Roch-Arveiller","year":"1990","journal-title":"Biochem. Pharmacol."},{"key":"2024103110013940900_cit8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0049-3848(95)93877-3","article-title":"Effects of thromboxane A2 synthase inhibitors (CV-4151 and ozagrel), aspirin and ticlopidine on the thrombosis caused by endothelial cell injury","volume":"77","author":"Terashita","year":"1995","journal-title":"Thromb. Res."}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.2042-7158.1998.tb03345.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/50\/11\/1275\/60261863\/j.2042-7158.1998.tb03345.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/50\/11\/1275\/60261863\/j.2042-7158.1998.tb03345.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T01:46:50Z","timestamp":1741139210000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/50\/11\/1275\/6153126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,11,1]]},"references-count":8,"journal-issue":{"issue":"11","published-online":{"date-parts":[[1998,11,1]]},"published-print":{"date-parts":[[1998,11,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.2042-7158.1998.tb03345.x","relation":{},"ISSN":["2042-7158","0022-3573"],"issn-type":[{"type":"electronic","value":"2042-7158"},{"type":"print","value":"0022-3573"}],"subject":[],"published-other":{"date-parts":[[1998,11]]},"published":{"date-parts":[[1998,11,1]]}}}